|
Congratulations to Cynda Rushton, who has just been selected in The Daily Record's Maryland's Top 100 women ! !
The Johns Hopkins Bloomerg School of Public Health and the Johns Hopkins Berman Institute of Bioethics offer a new course
Friday, March 07
The Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Berman Institute of Bioethics are pleased to offer a one-week intensive summer course entitled, “Ethics Issues in Human Subjects Research in Developing Countries.” The course is offered as part of the Johns Hopkins Graduate Summer Institute of Epidemiology and Biostatistics. Course enrolment is open to any interested practitioner, researcher, funder, faculty member, or student. Enrollees need not be affiliated with Johns Hopkins University.
Course dates: June 16 - June 20, 2008 (1:30 pm - 5:00 pm)
Location: Johns Hopkins Bloomberg School of Public Health (Baltimore, Maryland, U.S.A.)
Course summary:
Ethics Issues in Human Subjects Research in Developing Countries
(340.667.11) M, T, W, Th, F
This course will introduce those enrolled to ethical principles and formal codes of ethics, to key ethical issues that arise in international research. Ultimately, the course will be case-based to enable course participants to work through ethical challenges posed by research conducted in developing countries. Each daily session will be divided between a formal lecture and a case discussion. Case studies will be discussed in small groups and will be based on actual research projects in developing countries, including both clinical and epidemiological/observational research. The course is geared towards U.S. and international faculty, researchers, and students who conduct or fund research in developing country settings and to those who sit on IRBs/research ethics boards. Student evaluation is based on case study exercises and class participation. (2 academic credits)
Course faculty:
Nancy Kass, ScD, Professor, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health & Deputy Director, Berman Institute of Bioethics;
Andrea Ruff, MD, Associate Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health
For more information:
Please visit the Summer Institute’s website http://www.jhsph.edu/summerEpi/index.html
Contact:
Ayesha Khan
Coordinator
Graduate Summer Institute of Epidemiology and Biostatistics
Johns Hopkins Bloomberg School of Public Health
615 North Wolfe Street
Room W6508B
Baltimore, MD 21205
Phone: (410) 955-7158; Fax: (410) 955-0863
Email: akhan@jhsph.edu
Congratulations to Gail Geller, who has just been made full Professor in the Departments of Medicine, Pediatrics and Health Policy and Management!!
Berman Institue's Dr. Jeremy Sugarman has been appointed to ISSCR Task Force on the Clinical Translation of Stem CellsMonday, February 18
The ISSCR has convened a multinational task force to establish international guidelines for the clinical translation of stem cells and their direct derivatives. The ISSCR Task Force on the Clinical Translation of Stem Cells will define the scientific, clinical, regulatory, ethical, and societal issues that must be addressed to ensure that basic stem cell research is responsibly transitioned into appropriate clinical applications for treating patients. Berman Institue's Dr. Jeremy Sugarman has been appointed to this taskforce.
Dr. Ruth Faden to speak at NASI's 20th Annual Policy Conference
Thursday, January 31
"NASI’s 20th annual policy conference will focus on achieving affordable health coverage for all Americans. Taking place in the midst of the early Presidential primaries, the conference will bring together the major participants in the health coverage debate to frame the problem, compare specific policy proposals, and identify ways of overcoming the obstacles to reform." http://www.nasi.org/calendar_reg3634/calendar_reg_show.htm?doc_id=501818
Dr. Faden will speak on the first day of the conference January 31, 2008. She will speak during Session III on the topic "Ethical Implications of Policy Choices in Health Insurance."
Upcoming Embryonic Stem Cell Panel
Tuesday, January 22
Sponsored by the Bioethics Student Interest Group
6:00 pm
Mountcastle Auditorium, Preclinical Teaching Building at the Johns Hopkins School of Medicine.
Dinner will be provided just prior to the event.
Everyone is familiar with the controversy surrounding embryonic stem cells, but in the past few years, significant new scientific advances and increasing financial support from state governments have changed the political and ethical landscape of this issue. Here at Hopkins, many individuals continue to participate on a professional level in stem cell policy, research and regulation.
The Student Interest Group in Bioethics will be presenting a panel of Hopkins faculty on Tuesday, January 22 at 6pm in Mountcastle Auditorium, in the Preclinical Teaching Building of the School of Medicine. Our purpose is twofold: to provide a current update on stem cell science, policy and ethics and to directly expose members of the Hopkins community to the ongoing ethical dialogue.
Speakers will address a number of topics, ranging from an explanation of the new science of induced pluripotent stem cells to the story behind the Maryland Stem Cell Act of 2006.
Participants include:
John Gearhart, PhD, Co-Director, Stem Cell Biology Program, Institute for Cell Engineering (JHSOM)
Curt Civin, MD, PhD, Professor of Oncology and Samuelson Professor of Cancer Research, Johns Hopkins Kimmel Cancer Center
Paul McHugh, MD, Professor of Psychiatry, Member of the President’s Council on Bioethics
Debra Mathews, MPH, MA, Assistant Director for Science Programs, the Berman Institute of Bioethics
Moderator: Ruth Faden, PhD, MPH, Philip Franklin Wagley Professor of Biomedical Ethics and Executive Director, the Berman Institute of Bioethics
PLEASE RSVP IF YOU PLAN TO ATTEND to: jeddy1@jhmi.edu.
Check your email for further details in the coming weeks. We hope to see you there!
PhD Candidate Wins International Health Student Award
Posted October 17, 2007
Lori Uscher-Pines, MSc, a PhD candidate in the Johns Hopkins Bloomberg School of Public Health, has won a 2007 International Health Student Award from the American Public Health Association (APHA) for her work with Bloomberg and Berman Institute researchers. The APHA's International Health Section recognized Lori's work with Patrick Duggan, AB, Joshua Garoon, MPH, Ruth Karron, MD, and Ruth Faden, PhD, MPH, to produce Disadvantaged Groups in Pandemic Influenza Planning: An Analysis of National Plans.
Background
Evidence from previous disasters suggests that socially and economically disadvantaged groups suffer the greatest burdens both within and across countries. The potential for an influenza pandemic to create new or exacerbate existing social inequalities suggests the need to consider a pandemic not only as an urgent public health matter, but also as an urgent ethical and social justice issue. Aims/Methods: Thirty-seven national influenza pandemic plans were reviewed by three researchers to assess how countries addressed the needs and encouraged the participation of disadvantaged groups, in accordance with the recommendations of an international group of experts convened in July 2006. A data extraction instrument was developed to guide textual analysis and keyword searching. Results: Only three plans (8%) noted particular difficulties likely to be encountered by poor persons, and less than one-third of plans (all from high-income countries) made mention of socially disadvantaged groups such as ethnic minorities. Three (8%) plans specifically discussed policies to engage socially or economically disadvantaged groups in the planning process. Plans rarely addressed barriers such as assess to information that disadvantaged groups might face in the implementation of public health interventions. In general, the concept of “vulnerability” present in 20 plans (54%) suggested biological susceptibility to disease rather than to social or economic disadvantage. Conclusions: As plans are further developed, planners should take specific steps to ensure that disadvantaged groups receive appropriate consideration and should incorporate principles of social justice in planning. Furthermore, larger questions of global justice that arise between countries require further discussion and research, as they are likely to prove the most pressing if we hope to avert the most serious injustices that could result from a pandemic.
Learning Objectives:
Article © The Hastings Center. Reprinted with permission. This article originally appeared in the Hastings Center Report vol. 37, no. 4 (2007).” (www.thehastingscenter.org).
The award will be presented during the APHA's 135th annual meeting and exposition (November 3-7, 2007).
NEW - Risk Assessment Minor includes bioethics courses
Posted September 19, 2007
The Johns Hopkins Institute for NanoBioTechnology recently announced the development of a "Risk Assessment" minor into its curriculum. The new minor will likely involve a suite of courses on topics such as risk science and public policy; nanotechnology ethics, law and policy; environmental engineering; emerging environmental issues; environmental health; public health; and public health toxicology. Many of the faculty members who will develop or teach the courses are affiliated with the Berman Institute of Bioethics.
Bioethics and Health Policy Certificate
Posted August 16, 2007
The Johns Hopkins Bloomberg School of Public Health and the Berman Institute are now offering a certificate in Bioethics and Health Policy. The certificate is open to any Johns Hopkins students enrolled in a degree program in any division of Johns Hopkins University. The new certificate’s educational objectives are to:
1. Develop students' ability to recognize and analyze a moral problem in public health practice, research, and health policy;
2. Develop students' ability to further public policy debate concerning moral problems in public health practice, research, and health policy.
The certificate program is open to students enrolled in any graduate degree (Masters or Doctoral) program at any division of Johns Hopkins.
Learn more.
|
